Literature DB >> 25637235

[Severe linezolid-induced toxic optic neuropathy].

O Xerri1, B Lemaire2, G Nasser3, B Rousseau-Huvey4, M Labetoulle4, A Rousseau4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25637235     DOI： 10.1016/j.jfo.2014.05.020

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN： 0181-5512            Impact factor:   0.818


× No keyword cloud information.
  4 in total

1.  Linezolid Inhibited Synthesis of ATP in Mitochondria: Based on GC-MS Metabolomics and HPLC Method.

Authors:  Xuemei Ye; Aifang Huang; Xianqin Wang; Congcong Wen; Lufeng Hu; Guanyang Lin
Journal:  Biomed Res Int       Date:  2018-10-16       Impact factor: 3.411

Review 2.  Linezolid: a review of its properties, function, and use in critical care.

Authors:  Seyed Mohammad Reza Hashemian; Tayebeh Farhadi; Mojdeh Ganjparvar
Journal:  Drug Des Devel Ther       Date:  2018-06-18       Impact factor: 4.319

3.  Linezolid-Induced Toxic Optic Neuropathy.

Authors:  Meshaal A Aljebreen; Abdulaziz K Alotaibi; Malek Alrobaian
Journal:  Middle East Afr J Ophthalmol       Date:  2021-01-19

Review 4.  COVID-19 associated cranial nerve neuropathy: A systematic review.

Authors:  Josef Finsterer; Fulvio Alexandre Scorza; Carla Scorza; Ana Fiorini
Journal:  Bosn J Basic Med Sci       Date:  2022-02-01       Impact factor: 3.363
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.